These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 19244127)
21. A glioma classification scheme based on coexpression modules of EGFR and PDGFRA. Sun Y; Zhang W; Chen D; Lv Y; Zheng J; Lilljebjörn H; Ran L; Bao Z; Soneson C; Sjögren HO; Salford LG; Ji J; French PJ; Fioretos T; Jiang T; Fan X Proc Natl Acad Sci U S A; 2014 Mar; 111(9):3538-43. PubMed ID: 24550449 [TBL] [Abstract][Full Text] [Related]
22. Gliomas: advances in molecular analysis and characterization. Boudreau CR; Yang I; Liau LM Surg Neurol; 2005 Oct; 64(4):286-94; discussion 294. PubMed ID: 16229087 [TBL] [Abstract][Full Text] [Related]
23. Gene pathways and subnetworks distinguish between major glioma subtypes and elucidate potential underlying biology. Wuchty S; Zhang A; Walling J; Ahn S; Li A; Quezado M; Oberholtzer C; Zenklusen JC; Fine HA J Biomed Inform; 2010 Dec; 43(6):945-52. PubMed ID: 20828632 [TBL] [Abstract][Full Text] [Related]
24. Identification of a five B cell-associated gene prognostic and predictive signature for advanced glioma patients harboring immunosuppressive subtype preference. Zhang C; Li J; Wang H; Song SW Oncotarget; 2016 Nov; 7(45):73971-73983. PubMed ID: 27738332 [TBL] [Abstract][Full Text] [Related]
25. Robust meta-analysis shows that glioma transcriptional subtyping complements traditional approaches. Lee S; Piccolo SR; Allen-Brady K Cell Oncol (Dordr); 2014 Oct; 37(5):317-29. PubMed ID: 25142794 [TBL] [Abstract][Full Text] [Related]
27. Whole genome analysis from microdissected tissue revealed adult supratentorial grade II-III gliomas are divided into clinically relevant subgroups by genetic profile. Hirose Y; Sasaki H; Miwa T; Ohba S; Ikeda E; Abe M; Ikeda S; Kobayashi M; Kawase T; Hasegawa M; Yoshida K Neurosurgery; 2011 Aug; 69(2):376-90. PubMed ID: 21358357 [TBL] [Abstract][Full Text] [Related]
28. Expression-based intrinsic glioma subtypes are prognostic in low-grade gliomas of the EORTC22033-26033 clinical trial. Gao Y; Weenink B; van den Bent MJ; Erdem-Eraslan L; Kros JM; Sillevis Smitt P; Hoang-Xuan K; Brandes AA; Vos M; Dhermain F; Enting R; Ryan GF; Chinot O; Ben Hassel M; van Linde ME; Mason WP; Gijtenbeek JMM; Balana C; von Deimling A; Gorlia T; Stupp R; Hegi ME; Baumert BG; French PJ Eur J Cancer; 2018 May; 94():168-178. PubMed ID: 29571083 [TBL] [Abstract][Full Text] [Related]
29. Clinical insights gained by refining the 2016 WHO classification of diffuse gliomas with: EGFR amplification, TERT mutations, PTEN deletion and MGMT methylation. Brito C; Azevedo A; Esteves S; Marques AR; Martins C; Costa I; Mafra M; Bravo Marques JM; Roque L; Pojo M BMC Cancer; 2019 Oct; 19(1):968. PubMed ID: 31623593 [TBL] [Abstract][Full Text] [Related]
30. Molecular subtyping reveals immune alterations in IDH wild-type lower-grade diffuse glioma. Wu F; Li GZ; Liu HJ; Zhao Z; Chai RC; Liu YQ; Jiang HY; Zhai Y; Feng YM; Li RP; Zhang W J Pathol; 2020 Jul; 251(3):272-283. PubMed ID: 32418210 [TBL] [Abstract][Full Text] [Related]
31. A glycolysis-based ten-gene signature correlates with the clinical outcome, molecular subtype and IDH1 mutation in glioblastoma. Chen C; Shi Y; Li Y; He ZC; Zhou K; Zhang XN; Yang KD; Wu JR; Kung HF; Ping YF; Bian XW J Genet Genomics; 2017 Nov; 44(11):519-530. PubMed ID: 29169920 [TBL] [Abstract][Full Text] [Related]
32. Bioinformatic Profiling Identifies a Glucose-Related Risk Signature for the Malignancy of Glioma and the Survival of Patients. Zhao S; Cai J; Li J; Bao G; Li D; Li Y; Zhai X; Jiang C; Fan L Mol Neurobiol; 2017 Dec; 54(10):8203-8210. PubMed ID: 27900679 [TBL] [Abstract][Full Text] [Related]
33. [Towards a molecular classification of gliomas]. Hoang-Xuan K; Idbaih A; Mokhtari K; Sanson M Bull Cancer; 2005 Apr; 92(4):310-6. PubMed ID: 15888387 [TBL] [Abstract][Full Text] [Related]
34. Gene expression profiling of gliomas strongly predicts survival. Freije WA; Castro-Vargas FE; Fang Z; Horvath S; Cloughesy T; Liau LM; Mischel PS; Nelson SF Cancer Res; 2004 Sep; 64(18):6503-10. PubMed ID: 15374961 [TBL] [Abstract][Full Text] [Related]
35. Tissue Proteome Analysis of Different Grades of Human Gliomas Provides Major Cues for Glioma Pathogenesis. Gollapalli K; Ghantasala S; Atak A; Rapole S; Moiyadi A; Epari S; Srivastava S OMICS; 2017 May; 21(5):275-284. PubMed ID: 28481733 [TBL] [Abstract][Full Text] [Related]
36. Molecular Classification of Diffuse Gliomas. Kalidindi N; Or R; Babak S; Mason W Can J Neurol Sci; 2020 Jul; 47(4):464-473. PubMed ID: 31918786 [TBL] [Abstract][Full Text] [Related]
37. Current concepts in the pathology and genetics of gliomas. Sarkar C; Jain A; Suri V Indian J Cancer; 2009; 46(2):108-19. PubMed ID: 19346644 [TBL] [Abstract][Full Text] [Related]
38. Molecular Diagnostic and Prognostic Subtyping of Gliomas in Tunisian Population. Trabelsi S; Chabchoub I; Ksira I; Karmeni N; Mama N; Kanoun S; Burford A; Jury A; Mackay A; Popov S; Bouaouina N; Ben Ahmed S; Mokni M; Tlili K; Krifa H; Yacoubi MT; Jones C; Saad A; H'mida Ben Brahim D Mol Neurobiol; 2017 May; 54(4):2381-2394. PubMed ID: 26957305 [TBL] [Abstract][Full Text] [Related]
39. Individual Assignment of Adult Diffuse Gliomas into the EM/PM Molecular Subtypes Using a TaqMan Low-Density Array. Li J; Xue Y; Wenger A; Sun Y; Wang Z; Zhang C; Zhang Y; Fekete B; Rydenhag B; Jakola AS; Jiang T; Carén H; Fan X Clin Cancer Res; 2019 Dec; 25(23):7068-7077. PubMed ID: 31481507 [TBL] [Abstract][Full Text] [Related]
40. Characterization of gliomas: from morphology to molecules. Ferris SP; Hofmann JW; Solomon DA; Perry A Virchows Arch; 2017 Aug; 471(2):257-269. PubMed ID: 28674742 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]